Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI
- 24 February 2011
- journal article
- research article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 100 (8) , 649-659
Abstract
Background Blood glucose level at admission in ST-segment elevation myocardial infarction (STEMI) is a predictor of heart failure and mortality. This study was performed to investigate the impact of hyperglycemia at admission in non-diabetic patients on infarct size, microvascular obstruction, and long-term outcome using contrast-enhanced magnetic resonance imaging (CMR) in patients with acute STEMI. Methods One hundred and seven consecutive patients (84 males; mean age 59.4 years ± 11.3 years) with a first acute STEMI successfully treated by primary PCI were included. Admission hyperglycemia was defined as blood glucose above 7.8 mmol/l. CMR was performed 3.6 days ± 1.9 days after admission on a 1.5-tesla MR system. The imaging protocol included single-shot steady-state free precession (SSFP) cine sequences for assessing segmental and global left ventricular (LV) function and microvascular obstruction (MVO)/late gadolinium enhancement (LGE) imaging immediately and 10 min after the administration of 0.2 mmol gadodiamide/kg of body weight using an inversion-recovery SSFP (IR-SSFP) sequence. A receiver operating characteristics analysis was used to detect the best cut-off point of microvascular obstruction that predicted myocardial infarction and death during follow-up. Results Of 107 patients, 37 (35%) had hyperglycemia on admission. Compared to normoglycemic patients, patients with admission hyperglycemia had a lower LV ejection fraction (38.6 ± 13.7% vs. 47.5 ± 12.2%, p < 0.001), greater ESV (88.8 ± 41.8 ml vs. 72.3 ml ± 35.1 ml, p = 0.01), greater infarct size (LGE% 21.1 ± 14.9% vs. 9.8 ± 8.7%, p < 0.001), and greater MVO (MVO% 9.6 ± 9.9% vs. 2.5 ± 4.3%, p < 0.001). Admission hyperglycemia was an independent predictor of the presence and extent of microvascular obstruction. Microvascular obstruction as a percentage of left ventricular mass was the only variable independently related to clinical outcome in a Cox proportional hazard model (Wald 18.78, HR 1.155, p < 0.001). Conclusion Hyperglycemia at admission in STEMI patients who are successfully treated by PCI is independently associated with the presence and extent of microvascular obstruction on contrast-enhanced CMR. Thus, microvascular obstruction as assessed by CMR may be a mechanism that relates admission hyperglycemia in acute STEMI to worse outcome.Keywords
This publication has 47 references indexed in Scilit:
- Influence of small caliber coronary arteries on the diagnostic accuracy of adenosine stress cardiac magnetic resonance imagingClinical Research in Cardiology, 2010
- Microvascular Obstruction Remains a Portent of Adverse Remodeling in Optimally Treated Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial InfarctionCirculation: Cardiovascular Imaging, 2010
- Lessons Learned from the European Cardiovascular Magnetic Resonance (EuroCMR) Registry Pilot PhaseCurrent Cardiovascular Imaging Reports, 2010
- EuroCMR (European Cardiovascular Magnetic Resonance) RegistryJACC, 2009
- Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-Segment Elevation Myocardial InfarctionJournal of Cardiovascular Magnetic Resonance, 2008
- Insulin infusion therapy for myocardial infarctionExpert Opinion on Pharmacotherapy, 2006
- Myocardial Infarction and HyperglycemiaThe American Journal of Cardiology, 2005
- Diabetes and Stress Hyperglycemia Associated With Myocardial Infarctions at an Urban Municipal HospitalCardiology in Review, 2005
- Screening for Type 2 DiabetesDiabetes Care, 2003
- Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarctionJACC, 2003